Maarten van Lohuizen

5PUBLICATIONS
19CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 21, 2026
PRC2 loss impairs small cell lung cancer tumorigenesis and enhances sensitivity to G9a/GLP inhibition.

Jawahar Kopparam, Gayathri Chandrasekaran, Danielle Hulsman

|Mar 23, 2024
Combination of EZH2 and ATM inhibition in BAP1-deficient mesothelioma.

Nick Landman, Danielle Hulsman, Jitendra Badhai

|Dec 06, 2023
Combined Inhibition of EZH2 and FGFR is Synergistic in BAP1-deficient Malignant Mesothelioma.

Jitendra Badhai, Nick Landman, Gaurav Kumar Pandey

|May 01, 2019
EZH2 Is Overexpressed in BRCA1-like Breast Tumors and Predictive for Sensitivity to High-Dose Platinum-Based Chemotherapy.

Julian Puppe, Mark Opdam, Philip C Schouten

Pageof 1